In an awake adult with traumatic brain injury, intracranial hemorrhage and skull fracture, what oral medications should be started for seizure prophylaxis, analgesia, and stress‑ulcer prophylaxis, and when can chronic oral medications be resumed?

Oral Medication Management in Awake TBI Patients with Intracranial Hemorrhage and Skull Fracture

Seizure Prophylaxis

Routine antiepileptic prophylaxis is generally not recommended for traumatic brain injury, even in the presence of intracranial hemorrhage and skull fracture. 1

Evidence Against Routine Prophylaxis

• Analysis of 11 clinical trials involving over 2,700 patients found no significant effect of antiepileptic drugs in preventing early or delayed post-traumatic seizures 1
• Some studies demonstrated worsening neurological outcomes with antiepileptic prophylaxis, particularly with phenytoin 1
• The 2018 Anaesthesia guidelines provide a Grade 2- recommendation against using antiepileptic drugs for primary prevention 1

When to Consider Prophylaxis

If prophylaxis is deemed necessary due to multiple high-risk features (intracranial hemorrhage, skull fracture, and awake status suggesting moderate severity), levetiracetam should be strongly preferred over phenytoin. 1, 2

Levetiracetam Dosing Options:

• Standard dose: 1000 mg orally twice daily (preferred based on seizure reduction data) 3
• Lower dose: 500 mg orally twice daily may be considered, though patients receiving 1000 mg total daily dose had higher seizure incidence than those receiving >1000 mg daily 3, 4
• Duration: ≤7 days maximum if used 5

Key Advantages of Levetiracetam:

• Higher degree of tolerance compared to phenytoin 1
• Fewer drug interactions 2
• Fewer adverse effects (median 8% vs 21% with other agents) 6
• No cardiac monitoring required unlike phenytoin 1

Avoid Phenytoin Because:

• Associated with increased morbidity and mortality in patients with subdural hematoma 2
• Requires cardiac monitoring, slower to reach therapeutic levels (>5 hours orally), and has serious adverse effects including hypotension and bradyarrhythmias 1

Analgesia

For awake patients with TBI, avoid opioids that may cloud neurological assessment; use acetaminophen as first-line oral analgesia.

Practical Approach:

• Acetaminophen 650-1000 mg orally every 6 hours (does not impair mental status monitoring)
• Avoid NSAIDs due to bleeding risk with intracranial hemorrhage
• If opioids are necessary for severe pain, use short-acting agents in minimal doses with frequent neurological reassessment
• Document pain scores and mental status before and after each analgesic dose

Critical Caveat:

• Do not give oral medications to patients with decreased responsiveness or impaired protective airway reflexes 7
• Reassess swallowing ability before each oral medication administration

Stress Ulcer Prophylaxis

Proton pump inhibitors or H2-receptor antagonists should be initiated for stress ulcer prophylaxis in moderate-severe TBI patients.

Recommended Agents:

• Pantoprazole 40 mg orally once daily (preferred PPI)
• Alternative: Famotidine 20 mg orally twice daily (H2-blocker)
• These are standard critical care stress ulcer prophylaxis agents, though specific TBI guidelines do not mandate particular agents

Rationale:

• TBI patients requiring hospitalization are at increased risk for stress-related mucosal disease
• Oral administration is appropriate in awake, cooperative patients with intact swallow

Resumption of Chronic Oral Medications

Chronic oral medications can be resumed immediately in awake, cooperative patients with intact swallowing and stable neurological status.

Decision Algorithm:

1. Assess swallowing safety:

   • Patient is alert and following commands
   • No dysphagia or aspiration risk
   • Gag reflex intact

2. Review medication list for contraindications:

   • Hold anticoagulants/antiplatelets in the setting of acute intracranial hemorrhage until neurosurgical clearance
   • Hold sedating medications (benzodiazepines, sedating antihistamines) that may impair neurological monitoring
   • Continue essential medications (antihypertensives, cardiac medications, insulin/diabetes medications)

3. Blood pressure management considerations:

   • Target systolic BP >110 mmHg and <150 mmHg if within 6 hours of symptom onset and immediate surgery not planned 1
   • Adjust antihypertensive regimen accordingly

4. Timing:

   • Resume non-contraindicated chronic medications with the next scheduled dose
   • Do not delay essential medications (e.g., antihypertensives, antidiabetics) unnecessarily

Common Pitfalls to Avoid:

• Do not restart anticoagulation without imaging confirmation of hemorrhage stability and neurosurgical consultation
• Do not assume all home medications are appropriate—TBI may necessitate temporary discontinuation of CNS depressants
• Do not give oral medications if mental status deteriorates—this may indicate evolving intracranial pathology requiring urgent intervention 7
• Do not continue seizure prophylaxis beyond 7 days unless actual seizures occur 5
• Do not use phenytoin if levetiracetam is available due to worse tolerability and potential for neurological harm 1, 2